Indaptus Therapeutics Stock Analysis

Indaptus Stock Analysis Notes

About 27.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.7. Some equities with similar Price to Book (P/B) outperform the market in the long run. Indaptus Therapeutics recorded a loss per share of 1.7. The entity last dividend was issued on the 30th of October 2020. The firm had 1:4 split on the 27th of July 2021. Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York. Indaptus Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. To learn more about Indaptus Therapeutics call Jeffrey Meckler at 646 427 2727 or check out https://indaptusrx.com.

Indaptus Therapeutics Investment Alerts

Indaptus Therapeutics Upcoming and Recent Events

Indaptus Largest EPS Surprises

View All Earnings Estimates

Indaptus Stock Institutional Investors

Note, although Indaptus Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Indaptus Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.2 M.

Indaptus Profitablity

Management Efficiency

Indaptus Therapeutics has return on total asset (ROA) of (0.7112) % which means that it has lost $0.7112 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2704) %, meaning that it created substantial loss on money invested by shareholders. Indaptus Therapeutics' management efficiency ratios could be used to measure how well Indaptus Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/25/2024, Return On Tangible Assets is likely to drop to -1.09. In addition to that, Return On Capital Employed is likely to grow to -1.28. At this time, Indaptus Therapeutics' Total Current Liabilities is relatively stable compared to the past year. As of 11/25/2024, Liabilities And Stockholders Equity is likely to grow to about 23.5 M, while Non Current Liabilities Total is likely to drop slightly above 69.7 K.

Technical Drivers

As of the 25th of November, Indaptus Therapeutics retains the Risk Adjusted Performance of (0.04), standard deviation of 7.4, and Market Risk Adjusted Performance of (0.16). Indaptus Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Indaptus Therapeutics Price Movement Analysis

Indaptus Therapeutics Insider Trading Activities

Indaptus Therapeutics Outstanding Bonds

Indaptus Therapeutics Predictive Daily Indicators

Indaptus Therapeutics Forecast Models

Indaptus Therapeutics' time-series forecasting models are one of many Indaptus Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Indaptus Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Indaptus Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Indaptus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Indaptus Therapeutics. By using and applying Indaptus Stock analysis, traders can create a robust methodology for identifying Indaptus entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Indaptus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Indaptus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Indaptus Therapeutics stock analysis indicators help investors evaluate how Indaptus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Indaptus Therapeutics shares will generate the highest return on investment. By understating and applying Indaptus Therapeutics stock analysis, traders can identify Indaptus Therapeutics position entry and exit signals to maximize returns.

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.